The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((1H-1,2,4-triazol-3-yl)thio)-7-(benzyloxy)-6-methoxyquinazoline ID: ALA4877965
PubChem CID: 164628734
Max Phase: Preclinical
Molecular Formula: C18H15N5O2S
Molecular Weight: 365.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(Sc3nc[nH]n3)ncnc2cc1OCc1ccccc1
Standard InChI: InChI=1S/C18H15N5O2S/c1-24-15-7-13-14(8-16(15)25-9-12-5-3-2-4-6-12)19-10-20-17(13)26-18-21-11-22-23-18/h2-8,10-11H,9H2,1H3,(H,21,22,23)
Standard InChI Key: VGXQILSJTYIDKJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
3.6842 -18.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6831 -19.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3911 -19.8546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3893 -18.2173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0979 -18.6225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0987 -19.4416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8072 -19.8486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5155 -19.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5108 -18.6157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8016 -18.2123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9764 -18.2177 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2688 -18.6265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9750 -19.8537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2676 -19.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7973 -17.3951 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.5028 -16.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2501 -17.3067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7937 -16.6965 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3813 -15.9909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5829 -16.1652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5596 -19.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8509 -19.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1434 -19.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1423 -20.6702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8546 -21.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5593 -20.6695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 1 0
11 12 1 0
2 13 1 0
13 14 1 0
10 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
19 20 2 0
20 16 1 0
19 18 1 0
14 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.42Molecular Weight (Monoisotopic): 365.0946AlogP: 3.49#Rotatable Bonds: 6Polar Surface Area: 85.81Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.67CX Basic pKa: 1.59CX LogP: 3.91CX LogD: 3.91Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.52Np Likeness Score: -1.08
References 1. Li Z, Qin T, Li Z, Zhao X, Zhang X, Zhao T, Yang N, Miao J, Ma J, Zhang Z.. (2021) Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing., 225 [PMID:34416665 ] [10.1016/j.ejmech.2021.113778 ]